Do depressed patients on adjunctive atypical antipsychotics demonstrate a better quality of life compared to those on antidepressants only? A comparative cross-sectional study of a nationally representative sample of the US population
- PMID: 25023755
- DOI: 10.1016/j.sapharm.2014.06.001
Do depressed patients on adjunctive atypical antipsychotics demonstrate a better quality of life compared to those on antidepressants only? A comparative cross-sectional study of a nationally representative sample of the US population
Abstract
Background: The adjunctive use of some atypical antipsychotics (AAPs) has been popular for patients with treatment-resistant depression. However, little is known about the impact of these agents on patients' Health-related quality of life (HRQoL).
Objectives: The objective of this study is to examine the impact of the adjunctive AAPs use on HRQoL among users of antidepressants with self-reported depression.
Methods: Patients with depression (ICD-9-CM: 296, 300, and 311), and to have used the given AAPs and/or antidepressants for at least a year, were identified in the Medical Expenditure Panel Survey of 2008-2011. The patients were classified into users of adjunctive AAPs (i.e., antidepressants plus AAPs) and users of antidepressants only. Adjusted multivariate linear regression analyses were conducted to examine the association between the utilization of AAPs and HRQoL measure.(c)
Results: A total of 3638 participants who met the inclusion criteria were identified (306 on AAPs vs. 3332 on antidepressants only). The study subjects were ≥18 years, predominately White (91.9%) and female (71%). The AAPs utilization was not associated with higher scores in the Physical Component Summary (PCS-12) of the Short Form Health Survey (SF-12v2) (β = 1.542, 95% CI = -0.0142 to 3.0977, P = 0.0521). Rather, it was negatively associated with the Mental Component Summary (MCS-12) scores of the SF-12v2 (β = -1.5537, 95% CI = -3.0247 to -0.0827, P = 0.0385).
Conclusions: The utilization of AAPs was not associated with higher scores of HRQoL. The findings of this study should underscore the need to consider other treatment options as add-on therapy for depression before resorting to AAPs.
Keywords: Antidepressants (ATDs); Atypical antipsychotic agents (AAPs); Health-related quality of life (HRQoL); Mental Component Summary-12 (MCS-12); Physical Component Summary-12 (PCS-12); Short Form Health Survey-12 version two (SF-12v2).
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Comparison of health-related quality of life among patients using atypical antipsychotics for treatment of depression: results from the National Health and Wellness Survey.Health Qual Life Outcomes. 2012 Jul 17;10:81. doi: 10.1186/1477-7525-10-81. Health Qual Life Outcomes. 2012. PMID: 22805425 Free PMC article.
-
Depression treatment and health-related quality of life among adults with diabetes and depression.Qual Life Res. 2016 Jun;25(6):1517-25. doi: 10.1007/s11136-015-1189-y. Epub 2015 Nov 21. Qual Life Res. 2016. PMID: 26590839 Free PMC article.
-
Impact of depression treatment on health-related quality of life among adults with cancer and depression: a population-level analysis.J Cancer Surviv. 2017 Oct;11(5):624-633. doi: 10.1007/s11764-017-0635-y. Epub 2017 Aug 10. J Cancer Surviv. 2017. PMID: 28799098
-
Using antipsychotic agents in older patients.J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. J Clin Psychiatry. 2004. PMID: 14994733 Review.
-
What is the use? Application of the short form (SF) questionnaires for the evaluation of treatment effects.Qual Life Res. 2013 Aug;22(6):1225-30. doi: 10.1007/s11136-012-0266-8. Epub 2012 Sep 14. Qual Life Res. 2013. PMID: 22975926 Review.
Cited by
-
The relationship between self-reported antipsychotics side effects and depression in Saudi Arabia.Saudi Pharm J. 2024 Oct;32(10):102164. doi: 10.1016/j.jsps.2024.102164. Epub 2024 Aug 20. Saudi Pharm J. 2024. PMID: 39262682 Free PMC article.
-
Antidepressants and health-related quality of life (HRQoL) for patients with depression: Analysis of the medical expenditure panel survey from the United States.PLoS One. 2022 Apr 20;17(4):e0265928. doi: 10.1371/journal.pone.0265928. eCollection 2022. PLoS One. 2022. PMID: 35442954 Free PMC article.
-
The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.J Diabetes Complications. 2018 May;32(5):492-500. doi: 10.1016/j.jdiacomp.2017.12.008. Epub 2017 Dec 27. J Diabetes Complications. 2018. PMID: 29544744 Free PMC article.
-
Assessment of health-related quality of life, mental health status and psychological distress based on the type of pharmacotherapy used among patients with depression.Qual Life Res. 2017 Apr;26(4):969-980. doi: 10.1007/s11136-016-1417-0. Epub 2016 Sep 26. Qual Life Res. 2017. PMID: 27671488
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
